Crescendus

INDUSTRY DYNAMICS

Large companies (Pharma, Biotech, Generics, Diagnostics, Imaging, Medical Devices etc.) are struggling to maintain their R&D and Clinical Product Pipelines with innovative drug candidates that have the potential to replenish their declining revenue streams. In addition, they lack the know-how to deal with emerging concepts such as Companion Diagnostics (in vitro or in vivo) and Biomarkers.

Small and Medium scale companies, while rich in new concepts and technologies, lack the funding to survive the long clinical development timelines. In addition, university and other research institutions also lack the clinical and commercial capabilities to move the proof-of-concept technology to the clinical stage without an active partner.

CHALLENGES

The above constraints, coupled with the need to diversify into high value products, markets and disease areas, sets up an interesting demand for active deal making and licensing of technologies. With limited players, expect plenty of time tested tactics such as lengthy negotiations, over valuation of one's technology & importance, change of deal terms at the last minute, aggressive demands for exclusivity, first right of refusal and aloofness by larger players during critical periods of courting.

SOLUTION

Crescendus™ offers the following services to assist your Drug Licensing efforts:

• Industry Intelligence

• Scenario Planning and Analysis of Best Outcomes & Walk Away Strategies

• Business Development: Selection of Potential Partners, Negotiations, Deal Terms Finalization & Closing

• Market Opportunity Size & Valuation Analysis (incl. Revenue Sharing Mix, Royalties, Upfront, Milestone payments etc.)

• Alliance Management

USEFUL LINKS

Healthcare Focus

Drug Discovery & Development

Medical Devices & Diagnostics